Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Biolase Issued 2 More Laser Patents
Jul 2011
IRVINE, Calif., July 20, 2011 — Dental laser manufacturer and distributor Biolase Technology Inc. announced that it has received two more patents from the US Patent and Trademark Office for its laser technologies that treat various eye conditions, including presbyopia. The patents are the seventh and eighth to be issued under the “Methods for Treating Eye Conditions” patent family.

Patent number 7,967,017 includes 29 claims and introduces a strategy for identifying optimal treatment zones for the reversal of presbyopia – the age-related loss of near vision that affects everyone in midlife.

Patent number 7,909,040 includes 10 claims and relates to the shape of the treatment laser beam and specific ablative patterns for treating presbyopia.

The company currently holds 11 issued and 22 pending US and international patents in four patent families in the ophthalmology field.

For more information, visit:  

A state in which the human eye has very little or no power of accommodation. A common and normal condition in the eyes of those age 50 and older.
Americasbiolase technologyBiophotonicsBusinessCaliforniadental laserslaser ablative patternslaser beamsMethods for Treating Eye Conditionsnear-vision losspatent number 7909040patent number 7967017presbyopiaUS Patent and Trademark Officelasers

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.